VRXA is Veraxa Biotech AG (Healthcare) — a non-dividend-paying stock. Trading at $1.35. Market cap: $191M.
Stock snapshot
| Price | $1.35 |
| Market cap | $191M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
About VRXA
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
Related non-dividend companies
Other non-dividend stocks investors research alongside VRXA. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is VRXA's current stock price?
VRXA (Veraxa Biotech AG) is currently trading at $1.35.
Does VRXA pay a dividend?
VRXA (Veraxa Biotech AG) does not currently pay a regular dividend.
Track VRXA in DiviDrip
Add VRXA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search VRXA and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.